Husky Oak Limited is a private company limited by shares incorporated in England and Wales. The registered office is 78 York Street, London, United Kingdom, W1H 1DP.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
The average monthly number of persons (including directors) employed by the company during the year was:
Details of the company's subsidiaries at 31 December 2025 are as follows:
Included within total other creditors are loan notes of £1,500,000 which are repayable on demand and incur interest at 12%. The loans are secured by a guarantee from shares in the parent undertaking.
Interest is charged on £1,021,245 of an intercompany balance at 2.83%. The intercompany loan is unsecured.
Other creditors includes loans which are repayable over five years at an interest rate of 7%. The loans are secured by a guarantee from shares in the parent undertaking. £280,000 of this loan is shown as due in less than one year.
Interest is charged on a £2,101,377 intercompany balance at 4.82%. The intercompany loan is unsecured.
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.
The auditor's report is unqualified and includes the following:
On 31 March 2022, the company received a loan from its' European intermediary parent, M Logistical Holdings BV, to acquire 99.9% of the shareholding in Soak & Sleep Holdings Limited of £2,809,123.68. The total amount outstanding at year end was £2,459,124 (2024 - 2,459,124).
Also during 2022, as part of the acquisition of its investment, loan notes of £1,468,014 were issued to two of the directors. £895,496 (2024 - £895,496) of these loan notes remain outstanding at the year end. Interest of £107,459 (2024 - £107,459) has accrued on the loan during the year and £232,452 (2024 - £124,993) of the accrual remains outstanding at the year end. One of the directors also provided a loan of £350,000 in 2022 and this has accrued interest of £31,500 (2024 - £44,016) during the year. At the year end £350,000 (2024 - £350,000) of the loan and £118,837 (2024 - £87,337) of the interest remained outstanding.
Another director was issued £81,491 of loan notes as part of the acquisition of its investment and £49,710 (2024 - £49,710) of these loan notes remain outstanding at the year end. Interest of £5,965 (2024 - £5,965) has accrued on the loan during the year and £18,869 (2024 - £12,904) of the accrual remains outstanding at the year end.
The immediate parent company Malouf UK Limited loaned the company £1,081,107 during 2022 in order for it to repay part of the loan notes and accrued interest. This remained outstanding at the current year end and interest of £29,922 (2024 - £29,922) was accrued on £1,021,245 of the balance at a rate of 2.93%. The total interest outstanding at the year end was £104,729 (2024 - £74,806).
In 2024 Malouf UK Limited also loaned the company £2,101,377. The balance outstanding at the year end is £2,306,261 (2024 - £2,204,975). Interest of £101,286 (2024 - £103,598) has been charged on this loan at a rate of 4.82% per annum. The loan is disclosed within other creditors falling due within one year.
In 2024 the company loaned a subsidiary undertaking, Soak & Sleep Holdings Limited, £2,101,377. The balance outstanding at the year end is £2,303,950 (2024 - £2,202,663). Interest of £101,286 (2024 - £101,286) has been charged on this loan at a rate of 4.82% per annum.
During the year the company invoiced management charges of £nil (2024 - £nil) to Soak & Sleep Holdings Limited, a 99.9% owned subsidiary undertaking. At the year end the outstanding balance owed by Soak & Sleep Holdings Limited was £19,000 (2024 - £19,000).
Soak & Sleep Limited, also a 99.9% owned subsidiary undertaking, paid for £65,503 of services for the company in 2022. This balance remains outstanding at the current and prior year ends.